palbociclib 100 mg (CAPSULE)
|
$152.9183
|
|
AUS PBS
|
generic
|
Ibrance (21) |
Pfizer Australia Pty Ltd |
|
palbociclib 100 mg (CAPSULE)
|
$413.6962
|
|
VA Big4
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 100 mg (CAPSULE)
|
$546.0410
|
|
VA FSS
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 100 mg (TABLET)
|
$413.6962
|
|
VA Big4
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 100 mg (TABLET)
|
$512.3933
|
|
VA FSS
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 125 mg (CAPSULE)
|
$152.9183
|
|
AUS PBS
|
generic
|
Ibrance (21) |
Pfizer Australia Pty Ltd |
|
palbociclib 125 mg (CAPSULE)
|
$413.4724
|
|
VA Big4
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 125 mg (CAPSULE)
|
$546.0410
|
|
VA FSS
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 125 mg (TABLET)
|
$413.4724
|
|
VA Big4
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 125 mg (TABLET)
|
$512.3933
|
|
VA FSS
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 75 mg (CAPSULE)
|
$152.9183
|
|
AUS PBS
|
generic
|
Ibrance (21) |
Pfizer Australia Pty Ltd |
|
palbociclib 75 mg (CAPSULE)
|
$413.7714
|
|
VA Big4
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 75 mg (CAPSULE)
|
$546.0410
|
|
VA FSS
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 75 mg (TABLET)
|
$413.7714
|
|
VA Big4
|
|
Ibrance (21) |
Pfizer, Inc. |
|
palbociclib 75 mg (TABLET)
|
$512.3933
|
|
VA FSS
|
|
Ibrance (21) |
Pfizer, Inc. |
|